advanced search

<< Back To Home

WHAT'S NEW THIS MONDAY: DONOR FUNDING FOR NEWBORN SURVIVAL

Sunday, 31st of March 2013

 

•  UNICEF JOB POSTING, DAKAR, SENEGAL

Cold Chain and Logistics (CCL) Specialist, P4

Application Deadline:

 

15 April 2013  

UNICEF is a global leader in vaccine supply, reaching 40 per cent of the world’s children. Immunization is among the most successful, most equitable and most cost-effective public health interventions reaching four out of five children globally. We work with governments, partners and communities to increase demand for immunization establish better cold chain and logistic systems; design approaches to "Reach the Unreached"; and increase national ownership for immunization. Immunization is a central part of our commitment to protecting the world’s most vulnerable children, and we are looking for experienced Cold Chain and Logistics professionals to join our team.

Key Responsibilities

Under the guidance of the Regional Advisor Health (Immunization), key responsibilities include:

1. Provide appropriate technical support to countries to undertake the Effective Vaccine Management (EVM) assessment, to develop and implement the EVM-based improvement plan and to organize quality inventories and their follow up.

2. Identify country operational weaknesses in the field of Cold Chain and Vaccine management and opportunities for capacity building. Develop training activities specific to cold chain and vaccines management for the region, national and other partners, country offices.

3. Provide leadership, technical advice and guidance to Country Offices, Government counterparts and Partners on strategic and operational planning, to integrate of cold chain and logistic components into national plans and proposals and development/update of national strategies, tool and guidance on CCL policies and procedures integration.

4. Monitor the Cold chain and logistic procurement services (PS) and provide feedback to Country Offices and PS/Copenhagen on the appropriateness of cold chain equipment specifications and delivery. Contribute to the CCL component of the EPI reviews.

5. Develop and support the regional network of cold chain and logistic partners at regional level.

6. Participate in the preparation of all programme report for management, donors, programme analysis, annual reports etc.

Qualifications

1.

 

Advanced University Degree in Supply Chain Management or Public Health, or other academic qualifications in similar areas.

A first level university degree with a relevant combination of academic qualifications and experience may be accepted in lieu of the advanced university degree.

2. Minimum eight years of practical experience in managing complex and large cold chain and vaccine management operations involving planning, organizing, implementing and advisory support. Also considered to be additional strengths are varied logistics management experience in UNICEF or related field, and relevant experience in capacity building with specific proven experience in training.

3. Fluency in English and French is required.

To Apply

Please go to

http://bit.ly/11HWKwG or visit us at www.unicef.org/about/employ

to register in our e-Recruitment system, and search using keyword "cold chain" for additional details/to apply before deadline.

* Post is based in Dakar, with frequent mission travel to the 24 countries of the region.

 

 

 

Duty Station:

Dakar regional office, Senegal* Contract Type: Long Term Staff (FT)

• DONOR FUNDING FOR NEWBORN SURVIVAL: AN ANALYSIS OF DONOR-REPORTED DATA, 2002–2010

 

With recent increases in development assistance money for maternal and child health, Catherine Pitt and colleagues examine whether foreign aid specifically for newborns has changed, whether it's on par with the burden of newborn deaths worldwide, and how such funding can be tracked.

 

 

Catherine Pitt^1*, Joy E. Lawn², Meghna Ranganathan¹, Anne Mills¹, Kara Hanson¹ 

1 Department of Global Health & Development, London School of Hygiene & Tropical Medicine, London, United Kingdom, 2 Saving Newborn Lives/Save the Children, Cape Town, South Africa

Background

Neonatal mortality accounts for 43% of global under-five deaths and is decreasing more slowly than maternal or child mortality. Donor funding has increased for maternal, newborn, and child health (MNCH), but no analysis to date has disaggregated aid for newborns. We evaluated if and how aid flows for newborn care can be tracked, examined changes in the last decade, and considered methodological implications for tracking funding for specific population groups or diseases.

Methods and Findings

We critically reviewed and categorised previous analyses of aid to specific populations, diseases, or types of activities. We then developed and refined key terms related to newborn survival in seven languages and searched titles and descriptions of donor disbursement records in the Organisation for Economic Co-operation and Development's Creditor Reporting System database, 2002–2010. We compared results with the Countdown to 2015 database of aid for MNCH (2003–2008) and the search strategy used by the Institute for Health Metrics and Evaluation. Prior to 2005, key terms related to newborns were rare in disbursement records but their frequency increased markedly thereafter. Only two mentions were found of “stillbirth” and only nine references were found to “fetus” in any spelling variant or language. The total value of non-research disbursements mentioning any newborn search terms rose from US$38.4 million in 2002 to US$717.1 million in 2010 (constant 2010 US$). The value of non-research projects exclusively benefitting newborns fluctuated somewhat but remained low, at US$5.7 million in 2010. The United States and the United Nations Children's Fund (UNICEF) provided the largest value of non-research funding mentioning and exclusively benefitting newborns, respectively.

Conclusions

Donor attention to newborn survival has increased since 2002, but it appears unlikely that donor aid is commensurate with the 3.0 million newborn deaths and 2.7 million stillbirths each year. We recommend that those tracking funding for other specific population groups, diseases, or activities consider a key term search approach in the Creditor Reporting System along with a detailed review of their data, but that they develop their search terms and interpretations carefully, taking into account the limitations described.

Background

In 1990, 12 million children—most of them living in developing countries—died before they reached their fifth birthday. Faced with this largely avoidable loss of young lives, in 2000, world leaders set a target of reducing under-five mortality (deaths) to one-third of its 1990 level by 2015 as Millennium Development Goal 4 (MDG4); this goal, together with seven others, aims to eradicate extreme poverty globally. In recent years, progress towards reducing child mortality has accelerated but remains insufficient to achieve MDG4, in part, because progress towards reducing neonatal mortality—deaths during the first 28 days of life—has been particularly slow. Neonatal deaths now account for a greater proportion of global child deaths than in 1990—43% of the 7 million children who died before their fifth birthday in 2011 died during the neonatal period. The major causes of neonatal deaths are complications of preterm and term delivery and infections. Simple interventions such as improved hygiene at birth and advice on breastfeeding can substantially reduce neonatal deaths.

Why Was This Study Done?

To achieve MDG4, more must be done to prevent deaths among newborn babies. One reason that progress in reducing neonatal mortality is slow could be insufficient donor funding (aid) for newborn health. Previous analyses by, for example, Countdown to 2015 (which tracks coverage levels for health interventions that reduce maternal, newborn, and child mortality) indicate that donor funding has increased for maternal, newborn, and child health over the past decade, but how much of this aid directly benefits newborns is unknown. Here, the researchers develop a method for tracking aid flows for newborns and examine changes in this flow over the past decade by applying their new strategy to the Organisation for Economic Co-operation and Development (OECD) Creditor Reporting System (CRS) Aid Activity database. This database collects information about official development assistance for health given (disbursed) to developing countries by member countries of the OECD Development Assistance Committee, international organizations, and some private donors.

What Did the Researchers Do and Find?

The researchers developed a comprehensive set of search terms related to newborn survival by piloting it on the Countdown to 2015 official development assistance database, which covers the years 2003–2008. They then used their list of 24 key terms to search the CRS database from 2002 (the first year for which relatively complete disbursement data are available) to 2010 (the most recent year for which data are available) and classified each retrieved project according to whether its funding activities aimed to benefit newborns exclusively or to improve the health of other population groups as well. The researchers found that key terms related to newborns were rare in disbursement records before 2005 but that their frequency increased markedly thereafter. The total value of non-research disbursements (aid provided for programmatic or advocacy activities) that mentioned any newborn search terms increased from US$38.4 million in 2002 to US$717.1 million in 2010. The value of non-research projects that exclusively benefitted newborns fluctuated; in 2010, it was $US5.7 million. Finally, the US and United Nations Children's Fund (UNICEF) provided the largest value of non-research funding mentioning newborns and exclusively benefitting newborns, respectively.

What Do These Findings Mean?

These findings indicate that the value of aid disbursements mentioning newborns or an activity likely to benefit newborns increased 20-fold between 2002 and 2010 and constituted an increasing proportion of aid for maternal, newborn, and child health. Although this increase may partly reflect increased detail in aid disbursement reporting, it is also likely to reflect an increase in donor attention to newborn survival. The accuracy of these findings is likely to be affected by limitations in the search strategy and in the CRS database, which does not capture aid flows from emerging donors such as China or from many private foundations. Moreover, because these findings take no account of domestic expenditure, they do not provide a comprehensive estimate of the value of resources available in developing countries for newborn health. Nevertheless, investment in newborn survival is unlikely to be commensurate with global newborn mortality. Thus, an expansion of programmatic funding from donors as well as increased governmental support for newborn health in developing countries is urgently needed to catalyze the scale-up of cost-effective interventions to save newborn lives and to meet MDG4.